Cargando…
Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression
We examined the efficacy of using attenuated non-replicating Toxoplasma gondii uracil auxotrophs that can be safely delivered as anticancer immunotherapeutics. This strategy exerted remarkable therapeutic activity in murine models of melanoma and ovarian carcinoma, and holds broad potential for the...
Autores principales: | Fox, Barbara A, Sanders, Kiah L, Bzik, David J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862683/ https://www.ncbi.nlm.nih.gov/pubmed/24353916 http://dx.doi.org/10.4161/onci.26296 |
Ejemplares similares
-
Cancer therapy in a microbial bottle: Uncorking the novel biology of the protozoan Toxoplasma gondii
por: Fox, Barbara A., et al.
Publicado: (2017) -
Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity
por: Fox, Barbara A., et al.
Publicado: (2016) -
Genetic Manipulation in Δku80 Strains for Functional Genomic Analysis of Toxoplasma gondii
por: Rommereim, Leah M., et al.
Publicado: (2013) -
Rhoptry and Dense Granule Secreted Effectors Regulate CD8(+) T Cell Recognition of Toxoplasma gondii Infected Host Cells
por: Rommereim, Leah M., et al.
Publicado: (2019) -
Toxoplasma gondii Parasitophorous Vacuole Membrane-Associated Dense Granule Proteins Regulate Maturation of the Cyst Wall
por: Guevara, Rebekah B., et al.
Publicado: (2020)